Work

Genetic switch selectively kills hepatocellular carcinoma cell based on microRNA and tissue-specific promoter

Year: 2024

Type: article

Abstract: The clinical treatment of hepatocellular carcinoma (HCC) is still a heavy burden worldwide. Intracellular microRNAs (miRNAs) commonly express abnormally in cancers, thus they are potential therapeutic targets for cancer treatment. miR-21 is upregulated in HCC whereas miR-122 is enriched in normal hepatocyte but downregulated in HCC. In our study, we first generated a reporter genetic switch compromising of miR-21 and miR-122 sponges as sensor, green fluorescent protein (GFP) as reporter gene and L7Ae:K-turn as regulatory element. The reporter expression was turned up in miR-21 enriched environment while turned down in miR-122 enriched environment, indicating that the reporter switch is able to respond distinctly to different miRNA environment. Furthermore, an AAT promoter, which is hepatocyte-specific, is applied to increase the specificity to hepatocyte. A killing switch with AAT promoter and an apoptosis-inducing element, Bax, in addition to miR-21 and miR-122 significantly inhibited cell viability in Huh-7 by 70 % and in HepG2 by 60 %. By contrast, cell viability was not affected in five non-HCC cells. Thus, we provide a novel feasible strategy to improve the safety of miRNA-based therapeutic agent to cancer. • miR-21 is upregulated in hepatocellular carcinoma (HCC). • miR122 is enriched in normal hepatocyte but downregulated in HCC. • We employ miR-21 and miR-122 to discriminate HCC cell from non-HCC cells. • miRNA sponges combined with AAT promoter specifically kill HCC cell.

Source: Molecular and Cellular Probes

DOI: 10.1016/j.mcp.2024.101981